[{"Assets_0_Q3_USD":537680000.0,"CommonStockSharesOutstanding_0_Q3_shares":38443261.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-91659000.0,"NetIncomeLoss_1_Q3_USD":-52394000.0,"NetIncomeLoss_3_Q3_USD":-105479000.0,"StockholdersEquity_0_Q3_USD":446254000.0,"Ticker":"PRTA","CIK":"1559053","name":"PROTHENA CORP PLC","OfficialName":"Prothena Corporation plc Ordinary Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1633142175.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]